The biotech industry is at the cutting edge of modern healthcare and spearheads it by developing ground-breaking therapies and technologies that cater to underserved or previously unserved markets, thereby increasing the size of the pie for the healthcare industry.
Hence, attractively valued biotech stocks Biogen Inc. (BIIB), Cidara Therapeutics, Inc. (CDTX), and Theratechnologies Inc. (THTX) with healthy growth prospects are being pursued by smart money.
